Angilock® Plus

Losartan Potassium + Hydrochlorothiazide
AT1 receptor blocker combination (Cardiovascular Preparations)

Indication:

Angilock^® Plus is indicated for the treatment of hypertension. It is also indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy

Dosage & Administration:

The usual starting dose is Angilock^® Plus 50/12.5 one tablet once daily. More than two tablets of Angilock^® Plus 50/12.5 or one tablet of Angilock^® Plus 100/25 once daily is not recommended. Patients whose blood pressure is not adequately controlled with losartan or hydrochlorothiazide monotherapy, may be switched to Angilock^® Plus 50/12.5 once daily. If blood pressure remains uncontrolled after about three weeks of therapy, the dose may be increased to one tablet of Angilock^® Plus 100/12.5 or two tablets of Angilock^® Plus 50/12.5 or one Angilock^® Plus 100/25 once daily. Patients whose blood pressure is not adequately controlled with losartan 100 mg monotherapy, may be switched to Angilock^® Plus 100/12.5 once daily.

Preparation:

Angilock^® Plus 50/12.5 Tablet: Box containing 50 tablets in Alu-Alu blister pack.
Angilock^® Plus 100/12.5 Tablet: Box containing 30 tablets in Alu-Alu blister pack. ^® Plus 100/25 Tablet: Box containing 30 tablets in Alu-Alu blister pack.